© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 26, 2012
New Drug Review
The FDA approved Lundbeck, Inc's Onfi (clobazam) as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in patients that are 2 years and older.
April 09, 2012
Compliance with the much-anticipated implementation of the "Sunshine Act" will impact specialty pharmacies nationwide. Our experts take a closer look at the potential changes and how they will affect the industry now and in the future.
Specialty Pharmacy Nursing
Specialty nurses must be thoroughly trained on how to effectively and efficiently utilize a software system to deliver quality care to patients.
Viewpoints: The Last Word
The roots of specialty pharmacy began in community retail pharmacy. Given a choice, specialty patients will choose a local specialty pharmacy to access their medicines and manage their care.
All of the stakeholders agree that patient outcomes is a priority. Why do we allow fragmented patient care, payments, and delivery systems?
The new Final Rule to dispense all brand name drugs to Medicare Part D enrollees in long-term care facilities by the Centers for Medicare & Medicaid Services will impact pharmacists and patients.
Specialty pharmacy needs to raise the bar in data management and be ready for tomorrow as well as deliver superior patient care.
From the Chairman
The issue of adherence is critical and it impacts cost and delivery of care. As the population ages, medication adherence becomes even more of a focal point for health care professionals.
Disease State Management
April 05, 2012
As the population ages, the care of seniors is expanding and specialty pharmacists will play a more active role in patient management and collaboration with other health care providers.
Gilead Sciences, Inc's Complera received approval from the FDA for use as a complete regimen for the treatment of HIV-1 infection in treatment-naÃ¯ve adults.
Non-adherence to medications is one of the country's largest and most expensive disease categories. Specialty pharmacists play a vital role in improving adherence.
Pharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.
The rising cost of specialty drugs continues to put pressure on all stakeholders. Specialty pharmacists can fill an existing gap in compliance and cost control.
Overcoming the challenges to meet the special needs of long-term care patients, this pharmacy provides a careful approach that provides positive results.
As the country's population ages, providing quality care and accessible specialty pharmacy services is of the utmost importance. Here's a review of the key trends and major challenges.